BiondVax Presenting at BIO CEO & Investor Conference
JERUSALEM, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-03, 02:25
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-02, 02:42
Premiere Synthetic Biology Event on Track for Record
SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors, and location SAN FRANCISCO,...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-31, 21:19
Envision Pharma Group Hires Leading Industry Executives
PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Envision Pharma Group (Envision) today announced the appointment of two senior executives while further...
